Sculptor Capital’s T2 Biosystems, Inc TTOO Stock Holding History

Sculptor Capital’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6	Closed	-$159K	–	415
2016 Q4	$159K	Hold	6	–	–	﹤0.01%	298
2016 Q3	$219K	Buy	+6	New	+$197K	﹤0.01%	279

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sculptor Capital's TTOO Position: Q1 2017 in Review

Sculptor Capital sold out of T2 Biosystems, Inc (TTOO) in Q1 2017, closing a stake of 6 shares — an estimated $159K sold.

Sculptor Capital first reported a position in TTOO in Q3 2016 and held it in 2 quarters. The position peaked at $219K in Q3 2016. 34 funds tracked by Wall St. Rank hold TTOO as of Q1 2017.

Sculptor Capital reported no remaining T2 Biosystems, Inc position as of Q1 2017 after selling out during the quarter.
Sculptor Capital sold 6 T2 Biosystems, Inc shares in Q1 2017, an estimated $159K.
Sculptor Capital first reported a position in T2 Biosystems, Inc in Q3 2016 and held it in 2 quarters.
Sculptor Capital's T2 Biosystems, Inc position peaked at $219K in Q3 2016.
34 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2017.

Based on Sculptor Capital's 13F filing for Q1 2017, filed 12 May 2017.